What Heartflow, Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 18 | 38 |
| Total trades | 34 | 102 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 71,048 | 1,043,512 |
| Disposed | 340,639 | 9,377,305 |
| Net activity | −269,591 | −8,333,793 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rogers Campbell | Chief Medical Officer | Oct 22 | Open-market sale · S | −23,933 | $55.01 | −$1.32M | 73,453 |
| Rogers Campbell | Chief Medical Officer | Oct 22 | Exercise / conversion · M | +5,101 | $2.22 | +$11.3K | 97,386 |
| Rogers Campbell | Chief Medical Officer | Oct 22 | Exercise / conversion · M | +12,329 | $8.33 | +$103K | 92,285 |
| Farquhar John C.m. | Chief Executive Officer | Oct 12 | Open-market sale · S | −38,900 | $49.57 | −$1.93M | 283,014 |
| Verghese Vikram | Chief Financial Officer | Sep 18 | Open-market sale · S | −16,766 | $50.75 | −$851K | 155,183 |
| Rogers Campbell | Chief Medical Officer | Sep 18 | Open-market sale · S | −19,682 | $50.15 | −$987K | 79,956 |
| Rogers Campbell | Chief Medical Officer | Sep 18 | Exercise / conversion · M | +850 | $2.22 | +$1.89K | 99,638 |
| Rogers Campbell | Chief Medical Officer | Sep 18 | Exercise / conversion · M | +12,329 | $8.33 | +$103K | 98,788 |
| Verghese Vikram | Chief Financial Officer | Sep 17 | Open-market sale · S | −7,579 | $50.11 | −$380K | 171,949 |
| Verghese Vikram | Chief Financial Officer | Sep 15 | Open-market sale · S | −668 | $50.01 | −$33.4K | 179,528 |
| Verghese Vikram | Chief Financial Officer | Sep 14 | Open-market sale · S | −4,593 | $50.24 | −$231K | 180,196 |
| Farquhar John C.m. | Chief Executive Officer | Sep 11 | Open-market sale · S | −3,890 | $50.00 | −$195K | 321,914 |
| Verghese Vikram | Chief Financial Officer | Sep 11 | Open-market sale · S | −29,714 | $50.06 | −$1.49M | 184,789 |
| Farquhar John C.m. | Chief Executive Officer | Sep 10 | Open-market sale · S | −35,010 | $46.42 | −$1.63M | 325,804 |
| Verghese Vikram | Chief Financial Officer | Sep 08 | Open-market sale · S | −6,640 | $50.03 | −$332K | 214,503 |
| Verghese Vikram | Chief Financial Officer | Sep 03 | Open-market sale · S | −27,540 | $49.69 | −$1.37M | 221,143 |
| Verghese Vikram | Chief Financial Officer | Sep 02 | Open-market sale · S | −5,876 | $50.60 | −$297K | 248,683 |
| Farquhar John C.m. | Chief Executive Officer | Aug 21 | Open-market sale · S | −27,230 | $50.00 | −$1.36M | 360,814 |
| Farquhar John C.m. | Chief Executive Officer | Aug 18 | Open-market sale · S | −32,676 | $45.00 | −$1.47M | 388,044 |
| Rogers Campbell | Chief Medical Officer | Aug 17 | Open-market sale · S | −9,219 | $41.23 | −$380K | 86,459 |
Loading...